Advanced Filters
noise

sickle-cell-disease Clinical Trials

A listing of sickle-cell-disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 165 clinical trials
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies

Background People with sickle cell disease (SCD) have problems with their heart, brain, kidneys, liver, and lungs as they age. These problems may improve after transplant. Researchers want to learn how and why this happens. Objective To study the benefits of treatments that are intended to cure SCD. Eligibility People …

18 - 100 years of age All Phase N/A
D Damien JOLLY

Study of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA

Short description of the protocol intended for the lay public. Include a brief statement of the study hypothesis (Limit : 5000 characters) The sickle cells anemia is a monogenic disease linked to the presence of Hemoglobin S due to a mutation in the Hemoglobin Beta chain. The lack of circulating …

2 - 18 years of age All Phase N/A

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

QUELIMMUNE is FDA-approved under an HDE for the treatment of pediatric patients (weight ≥10kg and age ≤22 years) with AKI due to sepsis or a septic condition on antibiotic therapy and requiring RRT. The purpose of this surveillance registry is to prospectively collect safety data among all patients treated with …

- 22 years of age All Phase N/A
S Shi Chunxu

The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)

The goal of this clinical trial is to learn about the effects of social isolation and social interaction on the risk of dementia progression and brain function in SCD To explore the association between social isolation and lonely SCD populations and the occurrence and progression of MCI and AD through …

45 - 85 years of age All Phase N/A
C Carlo Ferrarese, MD

Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients

The goal of this observational study is to compare cerebral perfusion patterns with pseudo-continuous arterial spin labeling (pCASL) and brain metabolism patterns with fluorodeoxyglucose-position emission tomography (FDG-PET) in patients with mild cognitive impairment (MCI) and subjective cognitive decline (SCD). The main questions it aims to answer are Do pCASL sequences …

18 - 80 years of age All Phase N/A

Simplify language using AI